Total Visits

Views
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer38

Total Visits Per Month

July 2021August 2021September 2021October 2021November 2021December 2021January 2022
Immunohistochemical biomarkers are prognostic relevant in addition to the ESMO-ESGO-ESTRO risk classification in endometrial cancer000023015

File Visits

Views
gynonc_a2021v161p787.pdf16

Top country views

Views
United States9
China8
Ireland2

Top cities views

Views
Fairfield3
Woodbridge3
Fuzhou2
Houston2
Garden City1
Shenzhen1